To provide information about the effect of psychiatric comorbidities on wound healing in patients with diabetes mellitus (DM).TARGET AUDIENCE:
This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care.LEARNING OBJECTIVES/OUTCOMES:
After participating in this educational activity, the participant should be better able to:LEARNING OBJECTIVES/OUTCOMES:
1. Discuss the connection between DM and the development of psychiatric comorbidities.LEARNING OBJECTIVES/OUTCOMES:
2. Identify the drugs recommended in the treatment of these psychiatric comorbidities.LEARNING OBJECTIVES/OUTCOMES:
3. List cautions and contraindications related to the drugs discussed.
In patients with diabetes mellitus type 2, psychiatric comorbidities such as depressive and anxiety disorders are 60% or more prevalent than in the general population. The severity of mental illness and the duration of diabetes have been shown to correlate with worsening glycemic control, thus impeding wound healing. A retrospective chart review was conducted in all patients with diabetes mellitus admitted to the wound service with prior or current psychiatric symptoms of anxiety, depression, or cognitive impairment. A psychopharmacologic protocol was developed based on the clinical data collected and treatment parameters used by the behavioral health consultation liaison service.